Cellini N, Trodella L, Valentini V, Doglietto G B, Morganti A G, Ziccarelli P, Alfieri S, Bossola M, Brizi M G, Crucitti F
Cattedra di Radioterapia, Università Cattolica del S. Cuore, Policlinico A. Gemelli, Roma, Italy.
Rays. 1998 Jul-Sep;23(3):528-34.
Local recurrence affects approximately 50% of patients undergoing surgery for pancreatic adenocarcinoma. To lower the incidence of locoregional recurrence, the combination with surgery of adjuvant radiotherapy has been proposed. The latter is based on external radiotherapy (ERT), intraoperative radiotherapy (IORT) or their combination. To evaluate the impact on local control and survival, results achieved in a a group of patients undergoing surgical resection and combined adjuvant radiotherapy, are analyzed. 17 patients with adenocarcinoma of the exocrine pancreas were treated with a therapeutic protocol based on pancreatectomy and intraoperative radiotherapy (IORT) to the tumor bed (10 Gy) followed by postoperative radiotherapy (50 Gy); 9 patients underwent also preoperative radiotherapy (5 Gy) to the pancreas and liver. With a median follow-up of 45 months, in 3 patients (17.6%) local recurrence was observed while 12 patients (70.6%) showed liver metastases or peritoneal spread. Median survival was 17.5 months and actuarial survival at 2 and 5 years was 41.2% and 11.2%, respectively. As compared to a moderate local control, the prognosis of patients undergoing surgical resection remained disappointing. Thus, the effort of improving results with new therapeutic modalities as preoperative radiochemotherapy and adjuvant chemotherapy, seems justified.
局部复发影响了约50%接受胰腺癌手术的患者。为降低局部区域复发的发生率,有人提出将辅助放疗与手术联合应用。辅助放疗基于外照射放疗(ERT)、术中放疗(IORT)或二者联合。为评估其对局部控制和生存的影响,分析了一组接受手术切除并联合辅助放疗的患者所取得的结果。17例胰腺外分泌腺癌患者接受了基于胰腺切除术及对肿瘤床进行术中放疗(10 Gy),随后进行术后放疗(50 Gy)的治疗方案;9例患者还接受了对胰腺和肝脏的术前放疗(5 Gy)。中位随访45个月,观察到3例患者(17.6%)出现局部复发,12例患者(70.6%)出现肝转移或腹膜播散。中位生存期为17.5个月,2年和5年的精算生存率分别为41.2%和11.2%。与适度的局部控制相比,接受手术切除患者的预后仍然令人失望。因此,采用术前放化疗和辅助化疗等新治疗模式来改善治疗结果的努力似乎是合理的。